Virios Therapeutics, Inc. Profile Avatar - Palmy Investing

Virios Therapeutics, Inc.

Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed d…

Biotechnology
US, Alpharetta [HQ]
VIRI/Financials
Supply · Problems · Premarket · Compliance

Supply Analysis

Supply Analysis
End of VIRI's Analysis
CIK: 1818844 CUSIP: 92829J104 ISIN: US92829J1043 LEI: - UEI: -
Secondary Listings
VIRI has no secondary listings inside our databases.